Answers are grounded in this paper and cite their sources.
Crohn's disease in childhood is a chronic relapsing and remitting condition that can significantly impact normal growth and development. This influences choice of both initial and ongoing management. The goal of therapy is to induce and maintain remission with minimal side effects. Enteral nutrition is effective in active disease and will induce disease remission in most cases avoiding corticosteroid use. The high frequency of relapse means additional immunosuppressive therapies are usually required but nutrition remains a key priority as part of the subsequent management strategy.
No takes yet. Share an insight, caveat, or question.
R Mark Beattie (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: